Price
Financials
Standalone, Rs crore| Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|
| Sales | 21.25 | 28.40 | 35.07 | 35.76 |
| Expenses | 18.96 | 25.09 | 31.09 | 31.49 |
| Operating Profit | 2.29 | 3.31 | 3.98 | 4.27 |
| OPM % | 10.78% | 11.65% | 11.35% | 11.94% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.02 |
| Interest | 0.02 | 0.01 | 0.00 | 0.25 |
| Depreciation | 0.02 | 0.02 | 0.01 | 0.01 |
| Profit before tax | 2.25 | 3.28 | 3.97 | 4.03 |
| Tax % | 25.33% | 25.30% | 25.19% | 25.06% |
| Net Profit | 1.69 | 2.46 | 2.97 | 3.01 |
| EPS in Rs | 1.61 | 2.35 | 2.09 | 2.12 |
| Mar 2024 9m | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 31.60 | 49.65 | 70.83 |
| Expenses | 27.64 | 44.04 | 62.57 |
| Operating Profit | 3.96 | 5.61 | 8.26 |
| OPM % | 12.53% | 11.30% | 11.66% |
| Other Income | 0.01 | 0.00 | 0.02 |
| Interest | 0.06 | 0.04 | 0.26 |
| Depreciation | 0.02 | 0.03 | 0.03 |
| Profit before tax | 3.89 | 5.54 | 7.99 |
| Tax % | 25.19% | 25.09% | 25.16% |
| Net Profit | 2.91 | 4.14 | 5.98 |
| EPS in Rs | 5.94 | 3.96 | 4.21 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | % | % | % | 43% | ||
| Compounded Profit Growth | % | % | % | 44% | ||
| Stock Price CAGR | % | % | % | -30% | ||
| Return on Equity | % | % | 24% | 22% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Equity Capital | 4.90 | 10.47 | 14.21 |
| Reserves | 6.79 | 6.89 | 23.62 |
| Borrowings | 0.33 | 0.64 | 5.18 |
| Other Liabilities | 2.93 | 5.00 | 7.29 |
| Total Liabilities | 14.95 | 23.00 | 50.30 |
| Fixed Assets | 0.15 | 0.14 | 0.12 |
| CWIP | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 |
| Other Assets | 14.80 | 22.86 | 50.18 |
| Total Assets | 14.95 | 23.00 | 50.30 |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Cash from Operating Activity | -7.11 | 0.02 | -19.48 |
| Cash from Investing Activity | -0.15 | 0.00 | -0.01 |
| Cash from Financing Activity | 7.24 | 1.28 | 18.79 |
| Net Cash Flow | -0.02 | 1.30 | -0.70 |
| Free Cash Flow | -7.26 | 0.02 | -19.49 |
| CFO/OP | -180% | 0% | -224% |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Debtor Days | 158.82 | 147.84 | 202.98 |
| Inventory Days | 12.41 | 9.23 | 36.52 |
| Days Payable | 18.81 | 20.55 | 21.57 |
| Cash Conversion Cycle | 152.42 | 136.52 | 217.93 |
| Working Capital Days | 133.76 | 116.89 | 191.18 |
| ROCE % | 37.18% | 27.04% |
| Sep 2025 | Mar 2026 | |
|---|---|---|
| Promoters | 68.96% | 68.96% |
| Public | 31.04% | 31.04% |
| No. of Shareholders | 578 | 514 |
Fundamentals
Market Cap₹ 30.6 Cr.
Current Price₹ 21.5
Stock P/E5.11
Book Value₹ 26.6
ROCE27.0 %
ROE21.7 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)43%
Compounded Profit Growth (TTM)44%
Standalone figures.
Ownership
Promoter holding68.96%
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | MEDISTEP | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | +12.0% | -2.8% | +14.8 pts |
| 1 month | +9.3% | -6.8% | +16.1 pts |
| 3 months | +13.9% | -7.6% | +21.5 pts |
| 6 months | -20.4% | +0.4% | -20.8 pts |
Red flags
No red flags in the latest statements and filings.
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
No quarterly results published.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Godrej Consumer Products Ltd | 87,493 | 42.1 | 18.8 % |
| Dabur India Ltd | 67,481 | 34.0 | 20.3 % |
| Colgate-Palmolive (India) Ltd | 48,552 | 35.5 | 108 % |
| Cupid Ltd | 38,726 | 282 | 33.9 % |
| Gillette India Ltd | 22,694 | 34.0 | 90.7 % |
| Procter & Gamble Hygiene and Health Care Ltd | 22,305 | 28.2 | 157 % |
| Emami Ltd | 16,633 | 22.0 | 28.1 % |
| Honasa Consumer Ltd | 14,399 | 57.0 | 19.2 % |
| Bajaj Consumer Care Ltd | 6,439 | 28.9 | 30.0 % |
| Anondita Medicare Ltd | 2,085 | 62.3 | 43.8 % |
| Recode Studios Ltd | 454 | 40.5 | 74.1 % |
| Radix Industries (India) Ltd | 203 | 69.2 | 19.6 % |
| Macobs Technologies Ltd | 189 | 65.3 | 11.0 % |
| H. R. Hygiene Products Ltd | 156 | 13.7 | 30.4 % |
| Thrive Future Habitats Limited | 100 | -7.67 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Less than 100 unique PAN traded in previous 30 daysSME scrip is not regularly traded
Quick answers
What is the market cap of Medistep Healthcare Ltd?
Medistep Healthcare Ltd (MEDISTEP) has a market capitalisation of Rs 30.6 Cr. at the 2026-10-01 close.
What is the P/E ratio of Medistep Healthcare Ltd?
Medistep Healthcare Ltd trades at a P/E of 5.11 on trailing twelve-month profit, at the 2026-10-01 close.
What is the 52-week high and low of Medistep Healthcare Ltd?
The 52-week high is Rs 32.85 and the 52-week low is Rs 16.50.